Bioventus Inc.BVSNASDAQ
Loading
Cost of Revenue Over TimeStrong
Percentile Rank100
3Y CAGR+0.8%
5Y CAGR+16.2%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+0.8%/yr
vs +21.1%/yr prior
5Y CAGR
+16.2%/yr
Recent deceleration
Acceleration
-20.3pp
Decelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.1x
Strong expansion
Streak
5 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $185.66M | +0.3% |
| 2024 | $185.05M | +0.5% |
| 2023 | $184.15M | +1.7% |
| 2022 | $181.04M | +41.2% |
| 2021 | $128.19M | +46.3% |
| 2020 | $87.64M | -3.6% |
| 2019 | $90.94M | +8.0% |
| 2018 | $84.17M | -8.6% |
| 2017 | $92.10M | +0.8% |
| 2016 | $91.39M | - |